MYELODYSPLASIA, VASCULITIS AND ANTINEUTROPHIL CYTOPLASM ANTIBODIES

被引:35
作者
SAVIGE, JA
CHANG, L
SMITH, CL
DUGGAN, JC
机构
[1] University Department of Medicine, Austin Hospital Heidelberg, VIC
[2] Department of Haematology, Heidelberg Repatriation Hospital, Heidelberg, VIC
关键词
MYELODYSPLASTIC SYNDROMES; VASCULITIS; AUTOANTIBODIES; ANTINEUTROPHIL CYTOPLASM ANTIBODIES (ANCA);
D O I
10.3109/10428199309148503
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A cutaneous or systemic vasculitis occurs in myelodysplasia as well as in myeloproliferative and lymphoproliferative disorders. The most common lesion is a leucocytoclastic vasculitis, with neurological or joint involvement occurring less often. The vasculitis may appear contemporaneously with or precede the clinical onset of the blood dyscrasia. Occasionally the lesions respond dramatically to the use of steroids but in general, patients with vasculitis have a worse prognosis than those with uncomplicated myelodysplasia. Vasculitis and myelodysplasia appear together too often for the association to be coincidental and the vasculitis in most cases cannot be attributed to intercurrent infections, therapeutic agents or a pre-existing rheumatological disorder. While autoantibodies are frequently present in myelodysplasia, and ANA and anti-neutrophil cytoplasm antibodies (ANCA) are found in other vasculitides, neither of these antibodies is associated with the vasculitis of myelodysplasia. There has however been one report of ANCA in Sweet's syndrome a non-vasculitic skin condition that also occurs in the myelodysplastic syndromes.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 29 条
[11]  
Cines D.B., Lyss A.P., Reeber M., Bina M., De Horatius R.J., Presence of complement-fixing anti-endothelium cell antibodies in systemic lupus erythematosus, J. Clin. Invest., 73, pp. 611-625, (1984)
[12]  
Mufti G.J., Figes A., Hamblin T.J., Oscier D.G., Copplestone J.A., Immunological abnormalities in myelodysplastic syndromes, 1. Serum immunoglobulins and autoantibodies, Brit. J. Haem., 63, pp. 143-147, (1986)
[13]  
Solal Celigny P., Desaint B., Herrera A., Et al., Chronic myelomonocytic leukemia according to the FAB classification: analysis of 35 cases, Blood, 63, pp. 634-638, (1984)
[14]  
Laughter A.H., Lidsky M.D., Twomey J.J., Suppression of immunoglobulin synthesis by monocytes in health and in patients with systemic lupus erythematosus, Clin. Immunol. Immunopath., 14, pp. 435-440, (1979)
[15]  
Bynoe A.G., Scott C.S., Ford P., Roberts B.E., Decreased T helper cells in the myelodysplastic syndromes, Brit. J. Haem., 54, pp. 97-102, (1983)
[16]  
Petersen J., Rasmussen N.M., Szpirt W., Hermann E., Mayet W., T lymphocyte proliferation to neutrophil cytoplasmic antigen(s)in Wegener's granulomatosis, Am. J. Kid. Dis., XVIII, (1991)
[17]  
Heesen C., Kekow J., Rautmann A., Ulmer M., Gross W.L., Correlation of soluble interleukin-2 receptor (sIL-2R) levels with disease activity in Wegener's granulomatosis (WG), Am. J. Kid. Dis., XVIII, (1991)
[18]  
Jennette J.C., Falk R.J., Diagnostic classification of anti-neutrophil cytoplasmic autoantibody-associated vasculi-tides, Am. J. Kid. Dis., XVIII, pp. 184-187, (1991)
[19]  
Falk R.J., Jennette J.C., Anti-neutrophil cytoplasmic auto-antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis, New. Engl. J. Med., 318, pp. 1651-1657, (1988)
[20]  
Niles J.L., McCluskey R.T., Ahmad M.F., Arnaout M.F., Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase, Blood, 74, pp. 1888-1893, (1989)